skip to main content

By changing the way immune-based cancer drugs are given could reduce costs by 14%

An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.

Theranostics

Theranostics is a combination of the words, therapy and diagnostics, that refers to a type of cancer treatment. Theranostic pairs are 2 closely related radiopharmaceuticals with similar biodistribution when administered in the human body, one emits a diagnostic radiation that permits imaging and comprehensive cancer staging, the other delivers a therapeutic radiation particle to treat cancer metastases.

Gene therapy may prove helpful for blood disorders according to new research

Research from experts at Michigan Medicine, the Children’s Hospital of Philadelphia and Penn Medicine is breaking ground on new ways of treating blood disorders, such as sickle cell anemia, through gene therapy.

Rogel Cancer Center Members Attend Annual ASTRO Meeting

Rogel Cancer Center faculty and trainees will lead more than 20 presentations, posters and moderated sessions at ASTRO 2023 held October 1-4, at the San Diego Convention Center, San Diego, CA.

Thrive: Color Photography

Circular vessel brown in color appears woven but is pottery
Hope, color photography by Sarah Rypma

By Sarah Rypma

February through March, 2023

Bold, color photography by Sarah Rypma

Rogel awarded SPORE grant designed to further research on radiosensitization

An inter-departmental group of researchers at the Rogel Cancer Center received a grant from the National Cancer Institute to further research on radiosensitization, the process of making tumors more vulnerable to radiation treatment.

Research suggests glioblastomas contain active cells which control growth

Cancerous brain tumor cells may be at ‘critical point’ between order and disorder. Large-scale coordination of brain tumor behavior may allow tumor cells to resist better against therapies such as chemotherapy and radiation, researchers say.

Researchers discover PanIN lesions may not indicate likelihood of pancreatic cancer

In a study involving 30 pancreata from donors with no known gastrointestinal disease, researchers found precancerous lesions called pancreatic intraepithelial neoplasia in the majority of the organs. They also discovered that the lesions bore a similar gene expression signature to that of pancreatic cancer. These findings upend conventional wisdom that all PanIN are necessarily precursors to pancreatic cancer; given that the incidence of pancreatic cancer is relatively low, it’s not likely that all (or any) of the lesions are indicators of future cancer.

Pages